Addex Therapeutics Ltd (ADXN) is a Swiss biotechnology company focused on developing innovative drugs for the treatment of neurological and psychiatric disorders. The company leverages advanced technologies targeting allosteric modulation of receptors, enabling it to develop new therapeutic approaches for various conditions such as Parkinson's disease, schizophrenia, and other neurological disorders. Addex Therapeutics is known for its scientific expertise and strong focus on research and development. Addex Therapeutics Ltd (ADXN) shares could be suitable for investors looking for investments in the biotechnology and pharmaceutical research sector with an emphasis on innovative treatment methods.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
